Literature DB >> 2440681

Amino-acid sequence of human alpha 2-antiplasmin.

H R Lijnen, W E Holmes, B van Hoef, B Wiman, H Rodriguez, D Collen.   

Abstract

The amino-acid sequence of human alpha 2-antiplasmin was determined by Edman degradation of peptides purified from CNBr, tryptic and chymotryptic digests. Of the total sequence of 452 amino acids of mature alpha 2-antiplasmin, as deduced from the cDNA sequence [Holmes et al. (1987) J. Biol. Chem. 262, 1659-1664], 444 residues were identified by amino-acid sequencing. Two differences were found between the peptide and cDNA analyses (Gly instead of Leu at position 10 and Gly instead of Ser at position 369). alpha 2-Antiplasmin contains two disulfide bridges (Cys64-Cys104 and Cys31-Cys113) and four glucosamine-based carbohydrate chains attached to Asn87, Asn256, Asn270 and Asn277. alpha 2-Antiplasmin is homologous with 12 other proteins belonging to the serine protease inhibitor (serpin) superfamily.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440681     DOI: 10.1111/j.1432-1033.1987.tb13551.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.

Authors:  T L Lindahl; P I Ohlsson; B Wiman
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

2.  (99m)Tc-NC100668, a new tracer for imaging venous thromboemboli: pre-clinical biodistribution and incorporation into plasma clots in vivo and in vitro.

Authors:  David Edwards; Joanne Lewis; Mark Battle; Rochelle Lear; Gill Farrar; D Jon Barnett; Vanessa Godden; Alexandra Oliveira; Catherine Coombes; Håkan Ahlström
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-28       Impact factor: 9.236

3.  Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma.

Authors:  K Bangert; A H Johnsen; U Christensen; S Thorsen
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

4.  Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties.

Authors:  S Christensen; Z Valnickova; I B Thogersen; E H Olsen; J J Enghild
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

5.  Structural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution.

Authors:  K F Smith; R A Harrison; S J Perkins
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

6.  Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.

Authors:  D C Rijken; E Groeneveld; C Kluft; H K Nieuwenhuis
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

7.  On the localization of the cleavage site in human alpha-2-antiplasmin, involved in the generation of the non-plasminogen binding form.

Authors:  Shiraazkhan Abdul; Dick H W Dekkers; Robert A S Ariëns; Frank W G Leebeek; Dingeman C Rijken; Shirley Uitte de Willige
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

8.  Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin.

Authors:  Shiraazkhan Abdul; Miet Peeters; Els Brouwers; Joyce J M C Malfliet; Frank W G Leebeek; Paul J Declerck; Dingeman C Rijken; Shirley Uitte de Willige
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.